Grant: Operating Grant
McGill University
$100,000.00
Molecular basis and modulation of CFTR trafficking defect in respiratory epithelial cells
FY 2014-15
Summary
The cystic fibrosis protein (CFTR) resides at the cell surface and ensures normal water and ion content of the airway surface liquid. Mutations and chronic lung diseases can impair CFTR accumulation and function at the plasma membrane and consequentially reduce the amount and alter the composition of the airway surface liquid. We propose to elucidate the molecular basis of mutant CFTRs removal from the cell surface, the ionic compositional changes of ASL and its impact on the innate immune response. Novel assays and models will be implemented to identify small molecules and cellular proteins that can facilitate the correction of the mutant CFTR directly, or alleviate the consequences of its functional defect on the airway surface liquid composition and, thereby, the clinical manifestations of CF and other lung diseases.
Department
Program
Operating Grant
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
313966
Name
Lukacs Gergely L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Respiratory System
Projecttitle
Molecular basis and modulation of CFTR trafficking defect in respiratory epithelial cells
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cftr; Cystic Fibrosis; Cytokine; Degradation; Innate Immunity; Membraen Traffic; Misfolding; Phenotypic Screen; Ubiquitination
Abstract
The cystic fibrosis protein (CFTR) resides at the cell surface and ensures normal water and ion content of the airway surface liquid. Mutations and chronic lung diseases can impair CFTR accumulation and function at the plasma membrane and consequentially reduce the amount and alter the composition of the airway surface liquid. We propose to elucidate the molecular basis of mutant CFTRs removal from the cell surface, the ionic compositional changes of ASL and its impact on the innate immune response. Novel assays and models will be implemented to identify small molecules and cellular proteins that can facilitate the correction of the mutant CFTR directly, or alleviate the consequences of its functional defect on the airway surface liquid composition and, thereby, the clinical manifestations of CF and other lung diseases.
Competitiondate
201405
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lukacs, Gergely L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~